Showing results (31-40 of 164) with videos related to
Sort By:
Pageof 17
Investigational New Drugs|July 8, 2010
Cediranib in combination with various anticancer regimens: results of a phase I multi-cohort studyPatricia Lorusso, Anthony F Shields, Shirish Gadgeel, et al.Investigational New Drugs|August 4, 2011
A phase I pharmacokinetic and safety evaluation of oral pazopanib dosing administered as crushed tablet or oral suspension in patients with advanced solid tumorsElisabeth I Heath, Karen Forman, Lisa Malburg, et al.Journal of Clinical Pharmacology|October 20, 2009
Clinical pharmacokinetics and exposure-toxicity relationship of a folate-Vinca alkaloid conjugate EC145 in cancer patientsJing Li, Edward A Sausville, Patrick J Klein, et al.Investigational New Drugs|March 4, 2005
Phase II trial of fenretinide in advanced renal carcinomaUlka Vaishampayan, Lance K Heilbrun, Ralph E Parchment, et al.Plos One|April 16, 2011
Targeted morphoproteomic profiling of Ewing's sarcoma treated with insulin-like growth factor 1 receptor (IGF1R) inhibitors: response/resistance signaturesVivek Subbiah, Aung Naing, Robert E Brown, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2004
Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical centerMichael S Simon, Wei Du, Lawrence Flaherty, et al.Investigational New Drugs|July 3, 2013
Phase 1 dose-escalation, pharmacokinetic, and cerebrospinal fluid distribution study of TAK-285, an investigational inhibitor of EGFR and HER2Patricia LoRusso, Karthik Venkatakrishnan, E Gabriela Chiorean, et al.The Oncologist|February 12, 2015
Phase I dose-escalation study of pilaralisib (SAR245408, XL147), a pan-class I PI3K inhibitor, in combination with erlotinib in patients with solid tumorsJean-Charles Soria, Patricia LoRusso, Ratislav Bahleda, et al.Cancer Investigation|July 28, 2023
Platinum Sensitivity in IDH1/2 Mutated Intrahepatic Cholangiocarcinoma: Not All "BRCAness" Is Created EqualDeborah Blythe Doroshow, Wei Wei, Meenakshi Mehrotra, et al.Journal of Cancer Therapy|September 24, 2013
Physicians' Use of Patients' Daily Reports of Quality of Life to Evaluate Treatment Response in Phase I Cancer TrialsFelicity W K Harper, Elisabeth I Heath, Marci E J Gleason, et al.Pageof 17